Kieron Dunleavy

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BeiGene
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genmab
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Morphosys
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo
    Date added:
    03/16/2024
    Date updated:
    03/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pharmacyclics
    Date added:
    03/16/2024
    Date updated:
    03/16/2024

Pages

Return to Upstate New York Hematology & Hematologic Oncology Conference: Updates from the 65th ASH Annual Meeting